Practical syntheses of penciclovir and famciclovir from N2-acetyl-7-benzylguanine

Tetrahedron

Volumn 62, Issue 24, 2006, Pages 5709-5716

  Torii, Takayoshi ^a   Shiragami, Hiroshi ^a   Yamashita, Keizo ^a   Suzuki, Yumiko ^a   Hijiya, Toyoto ^a   Kashiwagi, Tatsuki ^a   Izawa, Kunisuke ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

Alkylation; Famciclovir; N9 selective; Penciclovir; Practical synthesis

Indexed keywords

ACETIC ACID DERIVATIVE; BENZYL DERIVATIVE; FAMCICLOVIR; GUANINE DERIVATIVE; GUANOSINE; HALIDE; MESYLIC ACID; N2 ACETYL 7 BENZYLGUANINE; PENCICLOVIR; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CATALYSIS; CHROMATOGRAPHY; DRUG SYNTHESIS; HYDROGENOLYSIS; HYDROLYSIS; PRIORITY JOURNAL;

FELINE CALICIVIRUS;

EID: 33646383581     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.03.080     Document Type: Article

References (41)

1. Schaeffer H.J., Beauchamp L., De Miranda P., Elion G.B., Bauer D.J., and Collins P. Nature 272 (1978) 583-585
2. Smith K.O., Galloway K.S., Kennell W.L., Ogilvie K.K., and Radatus B.K. Antimicrob. Agents Chemother. 22 (1982) 55-61
3. Ashton W.T., Karkas J.D., Fielf A.K., and Tolman R.L. Biochem. Biophys. Res. Commun. 108 (1982) 1716-1721
4. Smee D.F., Martin J.C., Verheyden J.P.H., and Matthews T.R. Antimicrob. Agents Chemother. 23 (1983) 676-682
5. Jarvest, R. L.; Harnden, M. R. EP Patent 141927, 1984.
6. Harnden, M. R.; Jarvest, R. L. EP Patent 182024, 1985.
7. Tippie M.A., Martin J.C., Smee D.F., Matthews T.R., and Verheyden J.P.H. Nucleosides Nucleotides 3 (1984) 525-535
8. It was discontinued to develop FCV 2 for the treatment of HBV infection due to poor clinical performance, See SmithKline Beecham plc, Press Release, April 20, 1999.
9. Pandit U.K., Grose W.F.A., and Eggelte T.A. Synth. Commun. 2 (1972) 345-351
10. Harnden M.R., and Jarvest R.L. Tetrahedron Lett. 26 (1985) 4265-4268
11. Geen G.R., Grinter T.J., Kincey P.M., and Jarvest R.L. Tetrahedron 46 (1990) 6903-6914
12. Geen G.R., Kincey P.M., and Choudary B.M. Tetrahedron Lett. 33 (1992) 4609-4612
13. Choudary B.M., Geen G.R., Grinter T.J., MacBeath F.S., and Parratt M.J. Nucleosides Nucleotides 13 (1994) 979-996
14. Choudary B.M., Geen G.R., Kincey P.M., Parratt M.J., Dales J.R.M., Johnson G.P., O'Donnell S., Tudor D.W., and Woods N. Nucleosides Nucleotides 15 (1996) 981-994
15. Kim D.-K., Lee N., Kim Y.-W., Chang K., Kim J.-S., Im G.-J., Choi W.-S., Jung I., Kim T.-S., Hwang Y.-Y., Min D.-S., Um K.A., Cho Y.-B., and Kim K.H. J. Med. Chem. 41 (1998) 3435-3441
16. Brand B., Reese C.B., Song Q., and Visintin C. Tetrahedron 55 (1999) 5239-5252
17. Freer R., Geen G.R., Ramsay T.W., Share A.C., Slater G.R., and Smith N.M. Tetrahedron 56 (2000) 4589-4595
18. Geen G.R., Kincey P.M., and Spoors P.G. Tetrahedron Lett. 42 (2001) 1781-1784
19. Kim D.-K., Kim Y.-W., and Lee N. J. Heterocycl. Chem. 38 (2001) 45-51
20. Toyokuni T., Walsh J.C., Namavari M., Shinde S.S., Moore J.R., Barrio J.R., and Satyamurthy N. Synth. Commun. 33 (2003) 3897-3905
21. Kaina B., and Aurich O. Mutat. Res. 139 (1984) 149-154 Mutagenic properties of 2-amino-6-chloropurine were observed by micronucleus and Ames tests, though NAc7BnG 7a was negative in Ames test. These tests were performed by Japan Biological Science Center Inc
22. Shiragami H., Ineyama T., Uchida Y., and Izawa K. Nucleosides Nucleotides 15 (1996) 47-58
23. Shiragami H., Koguchi Y., Tanaka Y., Takamatsu S., Uchida Y., Ineyama T., and Izawa K. Nucleosides Nucleotides 14 (1995) 337-340
24. Bridson P.K., Richmond G., and Yeh F. Synth. Commun. 20 (1990) 2459-2467
25. Izawa, K.; Shiragami, H.; Yamashita, K. EP Patent 728757, 1996.
26. Kobe, J.; Jaksa, S.; Kalayanov, G. WO Patent 2000006573, 2000.
27. Kalayanov G., Jaksa S., Scarcia T., and Kobe J. Synthesis (2004) 2026-2034
28. We had already reported the preliminary results of this study. See:. Izawa K., and Shiragami H. Pure Appl. Chem. 70 (1998) 313-318
29. Vanotti E., Bargiotti A., Biancardi R., Pinciroli V., Ermoli A., Menichincheri M., and Tibolla M. Tetrahedron 58 (2002) 3361-3370
30. Shiragami, H.; Uchida, Y.; Izawa, K.; Yamashita, K.; Katayama, S. EP Patent 827960, 1998.
31. Miyaki M., Saito A., and Shimizu B. Chem. Pharm. Bull. 18 (1970) 2459-2468
32. Shimizu, B.; Miyaki, M.; Saito, A. JP Patent 45026295, 1970.
33. +). See:. Hecht S.M., Adams B.L., and Kozarich J.W. J. Org. Chem. 41 (1976) 2303-2311. {A figure is presented}
34. Lindborg, B. G.; Datema, R.; Johansson, K. N. G.; Öeberg, Bo F. EP Patent 343133, 1989.
35. Harnden M.R., Jarvest R.L., Bacon T.H., and Boyd M.R. J. Med. Chem. 30 (1987) 1636-1642
36. Harnden M.R., Jarvest R.L., Boyd M.R., Sutton D., and Hodge R.A.V. J. Med. Chem. 32 (1989) 1738-1743
37. Robins M.J., and Uznański B. Can. J. Chem. (1981) 2601-2607
38. Muraoka M., Iwahara J., and Kaneko M. Chem. Pharm. Bull. 34 (1986) 2609-2613
39. Kozai S., Yorikane A., and Maruyama T. Nucleosides Nucleotides Nucleic Acids 20 (2001) 1523-1531
40. Matsuda A., Shinozaki M., Suzuki M., Watanabe K., and Miyasaka T. Synthesis (1986) 385-386
41. Shimizu B., and Miyaki M. Chem. Pharm. Bull. 15 (1967) 1066-1068